Media

Keep up to date with all the latest news and updates from Virax Biolabs.

 

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes

Read more

Virax Biolabs’ Q2 2026 Investor Presentation: Next-Generation Diagnostics for Chronic Inflammation and Immune Dysfunction

Read more

Virax Biolabs’ CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders

Read more

Discover Ways to Support Patients’ Health & Longevity Using Virax Biolabs’ Advanced Immunology Solutions

Read more

The Power of Peptides For Superior T Cell Stimulation

Read more

Virax Biolabs COO, Dr Nigel McCracken, Discusses Immune Decoding with ViraxImmune™ on the MedTech Gurus Podcast

Read more

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Read more

Major New Study Reveals Immunological Insights Into ME/CFS, Further Supporting Blood-based Diagnostic Testing and Research

Read more

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

Read more

Diagnosing Long COVID: A Gut-Immune Perspective.

Read more

Chronic Illness and The Immune System: Could ViraxImmune™ Offer a Critical Diagnostic Breakthrough?

Read more

Nigel McCracken, Virax COO, Discusses the New Frontier in Immune Diagnostics with The Scientist in This Innovation Spotlight.

Read more